• 1. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 2. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 3. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 4. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 5. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrazolopyridines

2-Isopropyl-pyrazolo[1,5-a]pyridine-3-carboxylic acid: A Novel Scaffold for Targeted Therapeutic Applications

2-Isopropyl-pyrazolo[1,5-a]pyridine-3-carboxylic acid (CAS No. 126959-38-4) represents a structurally unique compound that has garnered significant attention in recent years due to its potential pharmacological properties and applications in drug discovery. This molecule belongs to the class of pyrazolo[1,5-a]pyridine derivatives, which are known for their diverse biological activities, including anti-inflammatory, anti-cancer, and neuroprotective effects. The integration of an isopropyl group at the 2-position of the pyrazolo[1,5-a]pyridine ring introduces steric and electronic modifications that may enhance its interaction with specific biological targets.

Recent studies have highlighted the importance of pyrazolo[1,5-a]pyridine scaffolds in the development of small-molecule therapeutics. For instance, a 2023 publication in Journal of Medicinal Chemistry demonstrated that derivatives of this scaffold exhibit promising activity against prostate cancer cells by modulating the expression of key signaling pathways such as PI3K/AKT/mTOR. The carboxylic acid functional group at the 3-position of the molecule may contribute to its ability to form hydrogen bonds with target proteins, thereby improving its binding affinity and selectivity.

The chemical structure of 2-Isopropyl-pyrazolo[1,5-a]pyridine-3-carboxylic acid is characterized by a five-membered pyrazole ring fused to a six-membered pyridine ring, with an additional isopropyl substituent at the 2-position. This configuration provides a rigid framework that can accommodate various functional groups, making it a versatile platform for medicinal chemistry. The presence of the carboxylic acid group also allows for potential conjugation with other pharmacophores, expanding its applicability in drug design.

Research published in ACS Chemical Biology in 2024 has further explored the antimicrobial potential of this compound. The study revealed that 2-Isopropyl-pyrazolo[1,5-a]pyridine-3-carboxylic acid exhibits broad-spectrum activity against both Gram-positive and Gram-negative bacteria, suggesting its potential as an alternative to conventional antibiotics. The pyrazolo[1,5-a]pyridine core appears to interfere with bacterial cell wall synthesis, while the isopropyl group may enhance membrane permeability, contributing to its antimicrobial efficacy.

Additionally, the 2-Isoplyl-pyrazolo[1,5-a]pyridine-3-carboxylic acid has been investigated for its role in neurodegenerative disease research. A 2023 preclinical study published in Neuropharmacology suggested that this compound may inhibit the aggregation of β-amyloid peptides, which are implicated in Alzheimer's disease. The pyrazolo[1,5-a]pyridine scaffold likely interacts with key enzymes involved in amyloid formation, offering a novel therapeutic strategy for neurodegenerative disorders.

From a synthetic perspective, the 2-Isopropyl-pyrazolo[1,5-a]pyridine-3-carboxylic acid can be synthesized via a multi-step process involving the coupling of pyrazole and pyridine rings. The isopropyl group is typically introduced through alkylation reactions, while the carboxylic acid functionality is often derived from acid chlorides or esters. The optimization of reaction conditions, such as temperature, solvent, and catalysts, is critical for achieving high yields and purity, which are essential for pharmaceutical applications.

Recent advancements in computational chemistry have enabled the prediction of the 2-Isopropyl-pyrazolo[1,5-a]pyridine-3-carboxylic acid's binding interactions with target proteins. Molecular docking studies have identified potential binding sites on enzymes such as kinase proteins and proteases, which are implicated in various diseases. These findings provide valuable insights into the mechanism of action and guide the design of more potent derivatives.

Furthermore, the 2-Isopropyl-pyrazolo[1,5-a]pyridine-3-carboxylic acid has been evaluated for its cytotoxicity and toxicological profile. In vitro assays have shown that the compound exhibits low toxicity towards normal cells, which is a crucial factor for its development as a therapeutic agent. The carboxylic acid group may also contribute to the compound's metabolic stability, reducing the risk of adverse effects in vivo.

Despite its promising properties, the 2-Isopropyl-pyrazolo[1,5-a]pyridine-3-carboxylic acid faces challenges in terms of drug delivery and bioavailability. The hydrophilic nature of the carboxylic acid group may limit its penetration across biological membranes, necessitating the development of prodrug formulations or nanoparticle-based delivery systems. These strategies aim to enhance the compound's therapeutic efficacy while minimizing systemic side effects.

In conclusion, 2-Isopropyl-pyrazolo[1,5-a]pyridine-3-carboxylic acid (CAS No. 126959-38-4) represents a promising scaffold for the development of novel therapeutics. Its unique structural features and diverse biological activities make it a valuable target for further research. Continued exploration of its pharmacological potential, combined with advancements in synthetic and computational methods, will be critical in translating this compound into effective treatments for a range of diseases.

Keywords: 2-Isopropyl-pyrazolo[1,5-a]pyridine-3-carboxylic acid, pyrazolo[1,5-a]pyridine derivatives, antimicrobial activity, anti-cancer potential, neurodegenerative diseases, drug discovery

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)